Global Tigecycline Market, By Type (Gram Positive Bacteria and Gram Negative Bacteria), By Applicat

Published Date: | Report Code : HC1941574


Tigecycline Market is projected to register high demand during the forecast period with increasing demand from major end-use industries such as skin & soft tissue infections, complicated intra-abdominal infections, and community-acquired bacterial pneumonia  during the forecast period. Tigecycline is an antibiotic that is used to cure various bacterial infections. It exhibits the bacteriostatic activity due to the interaction of aminoacyl-tRNA with the A site of the ribosome by binding to the 30S ribosomal.

Due to the rising cases of skin infections caused by bacteria such as the escherichia coli and enterococcus faecalis, the demand for tigecycline is increasing.

Segment Analysis

The global tigecycline market has been segmented on the basis of type and application.

Based on type, the market has been segmented into gram positive bacteria and gram negative bacteria. Gram positive bacteria are used to target skin infections, which are generally caused by bacteria such as escherichia coli and enterococcus faecalis. However, gram negative bacteria include bacterium escherichia coli, which is fatal to humans and usually causes liver dysfunction or other intestinal infections. Thus, gram positive bacteria are widely used to cure abdominal infections.

Based on application, the market has been divided into skin & soft tissue infections, complicated intra-abdominal infections, and community-acquired bacterial pneumonia. Tigecycline is used widely for skin and soft tissue infections, as these infections are on the surface of the skin and the dosage of tigecycline required is not very strong.

Key Factors Impacting Market Growth:

  • Increasing demand for tigecycline as an antibiotic
  • Rising cases of medical conditions such as leukaemia and liver dysfunctions
  • An increasing number of skin infections caused by various bacteria such as escherichia coli and enterococcus faecalis

Regional Outlook:

North America, Western Europe, and Asia Pacific by region are estimated to dominate the tigecycline market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for tigecycline market during the forecast period. 

The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for tigecycline market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for tigecyclinemarket in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for tigecycline during the forecast period.

Companies Covered: Pfizer, Hisun Pharma, Hansoh Pharma, Jiagsu Aosaikang Pharmaceutical, HICIN Pharma, Abbott Laboratories, Amgen, Astrazeneca, Johnson & Johnson…

Market Segmentation:

By Type:

  • Gram Positive Bacteria
  • Gram Negative Bacteria

By Application:

  • Skin & Soft Tissue Infections
  • Complicated Intra-abdominal Infections
  • Community-acquired Bacterial Pneumonia

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Type
    • By Application
  • Western Europe
    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
    • By Type
    • By Application
  • Eastern Europe
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Type
    • By Application
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Type
    • By Application
  • Middle East
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
    • By Type
    • By Application
  • Rest of the World
    • By Region (South America, Africa)
    • By Type
    • By Application

Reasons to Buy This Report:

  • Market size estimation of the global tigecycline market on a regional and global basis
  • The unique research design for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market


We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)


Multi User (PDF)


Enterprise User (PDF)


 Regional Analysis

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy